Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/210406
Title: A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs
Author: Barbuti, Margherita
Menculini, Giulia
Verdolini, Norma
Pacchiarotti, Isabella
Kotzalidis, Georgios D.
Tortorella, Alfonso
Vieta i Pascual, Eduard, 1963-
Perugi, Giulio
Keywords: Medicaments
Trastorn bipolar
Depressió psíquica
Antidepressius
Drugs
Manic-depressive illness
Mental depression
Antidepressants
Issue Date: 1-Aug-2023
Publisher: Elsevier B.V.
Abstract: The present systematic review was aimed at critically summarizing the evidence about treatmentemergent manic/hypomanic and depressive switches during the course of bipolar disorder (BD). A systematic search of the MEDLINE, EMBASE, CINAHL, Web of Science, and PsycInfo electronic databases was conducted until March 24th , 2021, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Observational studies clearly reporting data regarding the prevalence of treatment-emergent mood switches in patients with BD were considered for inclusion. Thirty-two original studies met the inclusion criteria. In the majority of cases, manic switches were analyzed; only 3 papers investigated depressive switches in type I BD. Treatment-emergent mania/hypomania in BD subjects ranged from 17.3% to 48.8% and was more frequent with antidepressant monotherapy compared to combination treatment with mood stabilizers, especially lithium, or second-generation antipsychotics. A higher likelihood of mood switch has been reported with tricyclics and a lower rate with bupropion. Depressive switches were detected in 5-16% of type I BD subjects and were associated with first-generation antipsychotic use, the concomitant use of first- and second-generation antipsychotics, and benzodiazepines. The included studies presented considerable methodological heterogeneity, small sample sizes and comparability flaws. In conclusion, many studies, although heterogeneous and partly discordant, have been conducted on manic/hypomanic switches, whereas depressive switches during treatment with antipsychotics are poorly investigated. In BD subjects, both antidepressant and antipsychotic medications seems to play a role in the occurrence of mood switches, although the effects of different pharmacological compounds have yet to be fully investigated.
Note: Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2023.04.013
It is part of: European Neuropsychopharmacology, 2023, vol. 73, p. 1-15
URI: http://hdl.handle.net/2445/210406
Related resource: https://doi.org/10.1016/j.euroneuro.2023.04.013
ISSN: 0924-977X
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
262352.pdf2.48 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons